Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

R&D: a new world order

June 16, 2010 Manufacturing and Production, Research and Development industry, job cuts, research, research and development

Big pharma is today demolishing the in-house drug discovery and research structures built up over the last decade, and is …
Feature

Novavax makes manufacturing promotions

June 16, 2010 Manufacturing and Production, Research and Development Novavax, appointment, manufacturing and production, research and development

US biotech company Novavax has made a brace of manufacturing management promotions. It has appointed John Madsen as head of …
Appointment

Nexavar fails in lung cancer trial

June 15, 2010 Research and Development Bayer, NSCLC, Nexavar, Onyx

Bayer and Onyx Pharmaceutical’s oncology drug Nexavar has failed to meet its primary endpoint in a phase III study for …
News

Pfizer forms rare diseases unit

June 15, 2010 Research and Development Orphan, Pfizer

Pfizer is seeking to boost its coverage of research into orphan conditions with the creation of a new unit focused …
News

Early halt for successful apixaban trial

June 14, 2010 Research and Development apixaban, atrial fibrilation

Pfizer and Bristol-Myers Squibb’s atrial fibrillation treatment apixaban has performed so well in a phase III trial that it has …
News

Pharma pools trial data for brain disorder research

June 14, 2010 Research and Development Alzheimer's, Huntington's, Parkinson's, clinical trials, partnerships

Leading pharma companies have come together for a major new research collaboration aimed at improving clinical trials for Alzheimer’s, Parkinson’s, …
News

GSK-funded project will print APIs onto tablets

June 14, 2010 Manufacturing and Production, Research and Development GlaxoSmithKline, manufacturing, production, tablets

Researchers at GlaxoSmithKline and two UK universities are working on a technology that could allow active pharmaceutical ingredients to be …
News

Chiltern Launches Collaborative Technologies

June 11, 2010 Research and Development

Glenn Kerkhof, Chiltern CEO, commented, “A key benefit of Collaborative Technologies is the immediate access to current study information which …
News
Press release

Zactima promising in rare thyroid cancer

June 11, 2010 Research and Development, Sales and Marketing AstraZeneca, thyroid cancer, zactima

AstraZeneca’s Zactima (vandetanib) will be filed with regulators later this year as a treatment for thyroid cancer after promising results. …
News

Stem cells and patents: a potent mix

June 10, 2010 Research and Development Stem cells, stem cell

In recent years, there has been much debate about whether or not the use of stem cells in medical research …
Feature
Genzyme

Genzyme and Icahn agree compromise deal

June 10, 2010 Research and Development, Sales and Marketing Genzyme

Carl Icahn has won his battle with Genzyme to have his associates given a place on the company’s board.The US …
News
Blog footer

Digital Pharma: Online clinical collaboration

June 10, 2010 Research and Development biomarkers, digital doctors, digital pharma research, proteomic

A new online educational resource will offer researchers across the medical community access to peer-reviewed information on biomarkers. The portal …
News

Pfizer appoints neuroscience research head

June 10, 2010 Research and Development Pfizer, appointment, research and development

Pfizer has appointed Dr Michael Ehlers chief scientific officer for neuroscience research. Dr Ehlers most recently served as the George …
Appointment

‘Stellar’ performance from targeted lung cancer drug

June 9, 2010 Research and Development Pfizer, biomarkers, crizotinib

A new targeted treatment for non small cell lung cancer has produced spectacular results in a sub-group of patients. Pfizer’s …
News

Nerve gas antidote completes phase I trial

June 9, 2010 Research and Development Protalix, biodefence

Israeli biotech firm Protalix has completed a phase I clinical trial for its intravenous nerve gas antidote. The drug is …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025